Better Therapeutics Ownership 2024 | Who Owns Better Therapeutics Now?


OverviewForecastFinancialsChartTranscripts

Institutional Ownership

0.27%

Insider Ownership

53.34%

Retail Ownership

46.39%

Institutional Holders

3.00

Better Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CAPITAL INVESTMENT ADVISORY SERVICES, LLC0.18%0.00%71,000--994,000Mar 31, 2024
XTX TOPCO LTD0.08%0.00%32,67018,198125.75%457Mar 31, 2024
ASPIRE PRIVATE CAPITAL, LLC0.00%-200--3Mar 31, 2024
BANK OF AMERICA CORP /DE/----216-100.00%-Mar 31, 2024
WELLS FARGO & COMPANY/MN----179-100.00%-Mar 31, 2024
NORTHERN TRUST CORP----16,703-100.00%-Mar 31, 2024
STATE STREET CORP----58,600-100.00%-Mar 31, 2024
VANGUARD GROUP INC----198,154-100.00%-Mar 31, 2024
AMERIPRISE FINANCIAL INC----15,000-100.00%-Mar 31, 2024
GROUP ONE TRADING, L.P.----10,351-100.00%-Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC----168,821-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----128,749-100.00%-Mar 31, 2024
MMCAP INTERNATIONAL INC. SPC----356,270-100.00%-Mar 31, 2024
BLACKROCK INC.----88,635-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----3,000-100.00%-Mar 31, 2024
HRT FINANCIAL LP----25,312-100.00%-Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----22,443-100.00%-Mar 31, 2024
JANE STREET GROUP, LLC----10,336-100.00%-Mar 31, 2024
PSI ADVISORS, LLC----65-100.00%-Mar 31, 2024
CI PRIVATE WEALTH, LLC----29,180-100.00%-Mar 31, 2024

Better Therapeutics's largest institutional shareholder is CAPITAL INVESTMENT ADVISORY SERVICES, LLC, holding 0.18% of the company's total share outstanding, currently valued at $994.00K. The top 10 institutional shareholders own together 0.27% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CAPITAL INVESTMENT ADVISORY SERVICES, LLC0.18%0.00%71,000--994,000Mar 31, 2024
XTX TOPCO LTD0.08%0.00%32,67018,198125.75%457Mar 31, 2024
ASPIRE PRIVATE CAPITAL, LLC0.00%-200--3Mar 31, 2024
BANK OF AMERICA CORP /DE/----216-100.00%-Mar 31, 2024
WELLS FARGO & COMPANY/MN----179-100.00%-Mar 31, 2024
NORTHERN TRUST CORP----16,703-100.00%-Mar 31, 2024
STATE STREET CORP----58,600-100.00%-Mar 31, 2024
VANGUARD GROUP INC----198,154-100.00%-Mar 31, 2024
AMERIPRISE FINANCIAL INC----15,000-100.00%-Mar 31, 2024
GROUP ONE TRADING, L.P.----10,351-100.00%-Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC----168,821-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----128,749-100.00%-Mar 31, 2024
MMCAP INTERNATIONAL INC. SPC----356,270-100.00%-Mar 31, 2024
BLACKROCK INC.----88,635-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----3,000-100.00%-Mar 31, 2024
HRT FINANCIAL LP----25,312-100.00%-Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----22,443-100.00%-Mar 31, 2024
JANE STREET GROUP, LLC----10,336-100.00%-Mar 31, 2024
PSI ADVISORS, LLC----65-100.00%-Mar 31, 2024
CI PRIVATE WEALTH, LLC----29,180-100.00%-Mar 31, 2024

The largest Better Therapeutics shareholder by % of total assets is CAPITAL INVESTMENT ADVISORY SERVICES, LLC. The company owns 71.00K shares of Better Therapeutics (BTTX), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
XTX TOPCO LTD0.08%0.00%32,67018,198125.75%457Mar 31, 2024
ASPIRE PRIVATE CAPITAL, LLC0.00%-200--3Mar 31, 2024
CAPITAL INVESTMENT ADVISORY SERVICES, LLC0.18%0.00%71,000--994,000Mar 31, 2024
PSI ADVISORS, LLC----65-100.00%-Mar 31, 2024
WELLS FARGO & COMPANY/MN----179-100.00%-Mar 31, 2024
BANK OF AMERICA CORP /DE/----216-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----3,000-100.00%-Mar 31, 2024
JANE STREET GROUP, LLC----10,336-100.00%-Mar 31, 2024
GROUP ONE TRADING, L.P.----10,351-100.00%-Mar 31, 2024
AMERIPRISE FINANCIAL INC----15,000-100.00%-Mar 31, 2024
NORTHERN TRUST CORP----16,703-100.00%-Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----22,443-100.00%-Mar 31, 2024
HRT FINANCIAL LP----25,312-100.00%-Mar 31, 2024
CI PRIVATE WEALTH, LLC----29,180-100.00%-Mar 31, 2024
STATE STREET CORP----58,600-100.00%-Mar 31, 2024
BLACKROCK INC.----88,635-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----128,749-100.00%-Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC----168,821-100.00%-Mar 31, 2024
VANGUARD GROUP INC----198,154-100.00%-Mar 31, 2024
MMCAP INTERNATIONAL INC. SPC----356,270-100.00%-Mar 31, 2024

As of Mar 31 2024, Better Therapeutics's largest institutional buyer is XTX TOPCO LTD. The company purchased 18.20K stocks of BTTX, valued at $457.00.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MMCAP INTERNATIONAL INC. SPC----356,270-100.00%-Mar 31, 2024
VANGUARD GROUP INC----198,154-100.00%-Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC----168,821-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----128,749-100.00%-Mar 31, 2024
BLACKROCK INC.----88,635-100.00%-Mar 31, 2024
STATE STREET CORP----58,600-100.00%-Mar 31, 2024
CI PRIVATE WEALTH, LLC----29,180-100.00%-Mar 31, 2024
HRT FINANCIAL LP----25,312-100.00%-Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----22,443-100.00%-Mar 31, 2024
NORTHERN TRUST CORP----16,703-100.00%-Mar 31, 2024
AMERIPRISE FINANCIAL INC----15,000-100.00%-Mar 31, 2024
GROUP ONE TRADING, L.P.----10,351-100.00%-Mar 31, 2024
JANE STREET GROUP, LLC----10,336-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----3,000-100.00%-Mar 31, 2024
BANK OF AMERICA CORP /DE/----216-100.00%-Mar 31, 2024
WELLS FARGO & COMPANY/MN----179-100.00%-Mar 31, 2024
PSI ADVISORS, LLC----65-100.00%-Mar 31, 2024
CAPITAL INVESTMENT ADVISORY SERVICES, LLC0.18%0.00%71,000--994,000Mar 31, 2024
ASPIRE PRIVATE CAPITAL, LLC0.00%-200--3Mar 31, 2024
XTX TOPCO LTD0.08%0.00%32,67018,198125.75%457Mar 31, 2024

As of Mar 31 2024, Better Therapeutics's biggest institutional seller is MMCAP INTERNATIONAL INC. SPC. The company sold -0.36M shares of BTTX, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MMCAP INTERNATIONAL INC. SPC----356,270-100.00%-Mar 31, 2024
VANGUARD GROUP INC----198,154-100.00%-Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC----168,821-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----128,749-100.00%-Mar 31, 2024
BLACKROCK INC.----88,635-100.00%-Mar 31, 2024
STATE STREET CORP----58,600-100.00%-Mar 31, 2024
CI PRIVATE WEALTH, LLC----29,180-100.00%-Mar 31, 2024
HRT FINANCIAL LP----25,312-100.00%-Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----22,443-100.00%-Mar 31, 2024
NORTHERN TRUST CORP----16,703-100.00%-Mar 31, 2024
AMERIPRISE FINANCIAL INC----15,000-100.00%-Mar 31, 2024
GROUP ONE TRADING, L.P.----10,351-100.00%-Mar 31, 2024
JANE STREET GROUP, LLC----10,336-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----3,000-100.00%-Mar 31, 2024
BANK OF AMERICA CORP /DE/----216-100.00%-Mar 31, 2024
WELLS FARGO & COMPANY/MN----179-100.00%-Mar 31, 2024
PSI ADVISORS, LLC----65-100.00%-Mar 31, 2024

Better Therapeutics's largest sold out institutional shareholder by shares sold is MMCAP INTERNATIONAL INC. SPC, sold -0.36M shares, valued at -, as of undefined.

Better Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VICTORY PORTFOLIOS0.01%276,000--Dec 31, 2023
RIVERNORTH OPPORTUNITIES FUND, INC.0.00%3,461--Jan 31, 2024
VANGUARD INDEX FUNDS0.00%396,308-103,589-20.72%Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%165,724--Feb 29, 2024
iSHARES TRUST0.00%30,343--Feb 29, 2024
EQ ADVISORS TRUST0.00%1,113--Dec 31, 2023
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%627--Dec 31, 2023

Better Therapeutics's largest mutual fund holder by % of total assets is "VICTORY PORTFOLIOS", owning 276.00K shares, compromising 0.01% of its total assets.

Better Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 243-85.71%
31 Dec, 232116.67%
30 Sep, 231838.46%
30 Jun, 2313-18.75%
31 Mar, 2316-11.11%
31 Dec, 221838.46%
30 Sep, 221318.18%
30 Jun, 2211-8.33%
31 Mar, 2212-29.41%
31 Dec, 2117-

As of 31 Mar 24, 3 institutions are holding Better Therapeutics's shares, representing a decrease of -85.71% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 24103,870-92.74%
31 Dec, 231,430,851-43.11%
30 Sep, 232,515,186132.95%
30 Jun, 231,079,698-23.29%
31 Mar, 231,407,469-7.03%
31 Dec, 221,513,844-10.88%
30 Sep, 221,698,600-0.48%
30 Jun, 221,706,773-52.79%
31 Mar, 223,615,4692.33%
31 Dec, 213,533,122-

Better Therapeutics (BTTX) has 103.87K shares outstanding as of 31 Mar 24, down -92.74% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 240.27%1.95%
31 Dec, 233.72%5.73%
30 Sep, 238.06%39.24%
30 Jun, 234.53%12.99%
31 Mar, 235.91%14.53%
31 Dec, 226.38%12.40%
30 Sep, 227.17%13.70%
30 Jun, 227.23%3.03%
31 Mar, 2215.44%2.08%
31 Dec, 2127.21%-

As of 31 Mar 24, Better Therapeutics is held by 0.27% institutional shareholders, representing a 1.95% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 241-90.00%
31 Dec, 2310-
30 Sep, 2310150.00%
30 Jun, 234-20.00%
31 Mar, 235-44.44%
31 Dec, 22928.57%
30 Sep, 227-12.50%
30 Jun, 22860.00%
31 Mar, 225-68.75%
31 Dec, 2116-

1 institutional shareholders have increased their position in BTTX stock as of 31 Mar 24 compared to 10 in the previous quarter (a -90.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 24--100.00%
31 Dec, 235150.00%
30 Sep, 232-33.33%
30 Jun, 233-
31 Mar, 233-40.00%
31 Dec, 225150.00%
30 Sep, 222-
30 Jun, 222-60.00%
31 Mar, 225-
31 Dec, 21--

- institutional shareholders have reduced their position in BTTX stock as of 31 Mar 24 compared to 5 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 243-85.71%103,870-92.74%0.27%1.95%1-90.00%--100.00%
31 Dec, 232116.67%1,430,851-43.11%3.72%5.73%10-5150.00%
30 Sep, 231838.46%2,515,186132.95%8.06%39.24%10150.00%2-33.33%
30 Jun, 2313-18.75%1,079,698-23.29%4.53%12.99%4-20.00%3-
31 Mar, 2316-11.11%1,407,469-7.03%5.91%14.53%5-44.44%3-40.00%
31 Dec, 221838.46%1,513,844-10.88%6.38%12.40%928.57%5150.00%
30 Sep, 221318.18%1,698,600-0.48%7.17%13.70%7-12.50%2-
30 Jun, 2211-8.33%1,706,773-52.79%7.23%3.03%860.00%2-60.00%
31 Mar, 2212-29.41%3,615,4692.33%15.44%2.08%5-68.75%5-
31 Dec, 2117-3,533,122-27.21%-16---

Better Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 31, 2023PERRY DAVID Pdirector, 10 percent owner, officer Executive ChairmanP-PurchaseBuy1,233,045$0.73$900.00K13,030,393
Jul 31, 2023Berman Mark A.officer Chief Medical OfficerP-PurchaseBuy54,802$0.73$40.00K388,191
Jul 31, 2023Armanino Andrew J.director-P-PurchaseBuy274,010$0.73$200.00K728,368
Jul 31, 2023Granger Elderdirector-P-PurchaseBuy34,251$0.73$25.00K35,851

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 31, 2023PERRY DAVID Pdirector, 10 percent owner, officer Executive ChairmanP-PurchaseBuy1,233,045$0.73$900.00K13,030,393
Jul 31, 2023Berman Mark A.officer Chief Medical OfficerP-PurchaseBuy54,802$0.73$40.00K388,191
Jul 31, 2023Armanino Andrew J.director-P-PurchaseBuy274,010$0.73$200.00K728,368
Jul 31, 2023Granger Elderdirector-P-PurchaseBuy34,251$0.73$25.00K35,851

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Dec 07, 2023Miller Leslie A.officer Principal Accounting OfficerSell---14,350
Dec 07, 2023Miller Leslie A.officer Principal Accounting OfficerSell16,100$10.97$176.62K-
Dec 07, 2023Miller Leslie A.officer Principal Accounting OfficerSell11,100$1.97$21.87K-
Dec 07, 2023Miller Leslie A.officer Principal Accounting OfficerSell9,650$1.14$11.00K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Feb 13, 2024PERRY DAVID Pdirector, 10 percent owner, officer Executive ChairmanA-AwardBuy839,895$0.19$160.00K2,416,634
Jan 10, 2024PERRY DAVID Pdirector, 10 percent owner, officer Executive ChairmanA-AwardBuy1,471,453$0.17$250.00K1,576,739
Dec 20, 2023PERRY DAVID Pdirector, 10 percent owner, officer Executive ChairmanA-AwardBuy3,750--105,286
Dec 20, 2023Carmona Richard Hdirector-A-AwardBuy3,750--157,369
Dec 20, 2023LAVIZZO-MOUREY RISA Jdirector-A-AwardBuy3,750--13,750
Dec 20, 2023Wynholds Kristinofficer Chief Product OfficerA-AwardBuy25,362--225,631
Dec 20, 2023Parker Geoffrey M.director-A-AwardBuy3,750--1,031,805
Dec 20, 2023Armanino Andrew J.director-A-AwardBuy3,750--17,084
Dec 20, 2023Miller Leslie A.officer Principal Accounting OfficerA-AwardBuy3,587--17,937
Dec 20, 2023Granger Elderdirector-A-AwardBuy3,750--39,601
Dec 20, 2023KARBE FRANKdirector, officer Chief Executive OfficerA-AwardBuy62,500--526,516
Dec 20, 2023Berman Mark A.officer Chief Medical OfficerA-AwardBuy25,362--448,140
Dec 07, 2023Miller Leslie A.officer Principal Accounting OfficerSell---14,350
Dec 07, 2023Miller Leslie A.officer Principal Accounting OfficerSell16,100$10.97$176.62K-
Dec 07, 2023Miller Leslie A.officer Principal Accounting OfficerSell11,100$1.97$21.87K-
Dec 07, 2023Miller Leslie A.officer Principal Accounting OfficerSell9,650$1.14$11.00K-
Jul 31, 2023PERRY DAVID Pdirector, 10 percent owner, officer Executive ChairmanP-PurchaseBuy1,233,045$0.73$900.00K13,030,393
Jul 31, 2023Berman Mark A.officer Chief Medical OfficerP-PurchaseBuy54,802$0.73$40.00K388,191
Jul 31, 2023Armanino Andrew J.director-P-PurchaseBuy274,010$0.73$200.00K728,368
Jul 31, 2023Granger Elderdirector-P-PurchaseBuy34,251$0.73$25.00K35,851

The last insider sell of Better Therapeutics's stock was made by Miller Leslie A. on Dec 07 2023, selling - shares at - per share (valued at -). The last insider buy of BTTX was made by PERRY DAVID P on Jul 31 2023, buying 1,233,045 shares at $0.73 per share (worth $900.00K).

Better Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 20241--
Q4 2023104250.00%
Q3 20236--
Q2 20231511500.00%
Q1 20233--
Q4 20222--
Q3 20226--
Q2 20221711700.00%
Q1 20226--
Q4 20213414242.86%
Q2 202173233.33%
Q1 2021123400.00%
Q1 2020-1-

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Better Therapeutics's insiders, as of Q1 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2024---
Q4 2023---
Q3 20236--
Q2 20236--
Q1 2023---
Q4 2022---
Q3 20225--
Q2 20225--
Q1 20224--
Q4 202114--
Q2 202173233.33%
Q1 202112--
Q1 2020---

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Better Therapeutics's stocks.

Better Therapeutics Peer Ownership


TickerCompany
ANTXAN2 Therapeutics, Inc.
ANEBAnebulo Pharmaceuticals, Inc.
SNTISenti Biosciences, Inc.
RZLTRezolute, Inc.
PMVPPMV Pharmaceuticals, Inc.
TERNTerns Pharmaceuticals, Inc.
ABOSAcumen Pharmaceuticals, Inc.
BLCMBellicum Pharmaceuticals, Inc.
INDPIndaptus Therapeutics, Inc.
IKTInhibikase Therapeutics, Inc.
INZYInozyme Pharma, Inc.
AVTEAerovate Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
DAWNDay One Biopharmaceuticals, Inc.
CINGCingulate Inc.
KTTAPasithea Therapeutics Corp.
ABVCABVC BioPharma, Inc.
HILSTharimmune, Inc.
FBRXForte Biosciences, Inc.
HOOKHOOKIPA Pharma Inc.
ADAGAdagene Inc.

BTTX Ownership FAQ


Better Therapeutics is owned by institutional shareholders (0.27%), insiders (53.34%), and public (46.39%). The largest institutional shareholder of Better Therapeutics is CAPITAL INVESTMENT ADVISORY SERVICES, LLC (0.18% of total shares) and the top mutual fund owner is VICTORY PORTFOLIOS (0.01% of total shares).

Better Therapeutics's major institutional shareholders are CAPITAL INVESTMENT ADVISORY SERVICES, LLC, XTX TOPCO LTD, ASPIRE PRIVATE CAPITAL, LLC, BANK OF AMERICA CORP /DE/, and WELLS FARGO & COMPANY/MN. The top five shareholders own together 0.27% of the company's share outstanding.

As of Mar 2024, there are 3 institutional shareholders of Better Therapeutics.

CAPITAL INVESTMENT ADVISORY SERVICES, LLC owns 71K shares of Better Therapeutics, representing 0.18% of the company's total shares outstanding, valued at $994K (as of Mar 2024).

As of Mar 2024, XTX TOPCO LTD holds 32.67K shares of Better Therapeutics (BTTX), compromising 0.08% of the company, valued at $457.

ASPIRE PRIVATE CAPITAL, LLC is the third largest holder of Better Therapeutics. The company owns 200 of the company's shares outstanding (worth $3).